Study on clinicopathological features and prognosis of HER2 low expression breast cancer

Study on clinicopathological features and prognosis of HER2 low expression breast cancer

Objective This study explores the clinicopathological features and prognosis of breast cancer with low expression of human epidermal growth factor receptor 2 (HER2), and analyzes the main factors that influence the consistency of HER2 immunohistochemical interpretation. Methods A total of 237 cases...

Full description

Saved in:

Bibliographic Details
Main Author:	RUAN Miao, DA Qian, XU Haimin, DONG Lei, FEI Xiaochun
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2024-10-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|breast cancer\|immunohistochemistry\|her2 low expression\|clinicopathological features\|prognosis
Online Access:	https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1740454616773-885776193.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01)

Unveiling HER2 immunoexpression in canine hepatoid gland neoplasms: clinicopathological and morphological associations
by: Hassadin Boonsriroj, et al.
Published: (2025-12-01)

Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study
by: Karen Van Baelen, et al.
Published: (2025-06-01)

Clinicopathological features and prognosis of mucinous breast carcinoma with a micropapillary structure
by: Beibei Yang, et al.
Published: (2024-12-01)

Relationship Between YWHAQ Expression and Clinicopathological Features and Prognosis of Patients with Gastric Adenocarcinoma
by: Xueqing LIU, et al.
Published: (2025-05-01)

Clinical characteristics and therapeutic direction of HER2 low-expression breast cancer
by: Linlin Zhou, et al.
Published: (2025-02-01)

Prevalence and Clinicopathologic Features of HER2 Overexpression in Endocervical Adenocarcinoma
by: Niusha Momeni, et al.
Published: (2025-07-01)

Accuracy of human epidermal growth factor receptor 2 (HER2) immunohistochemistry scoring by pathologists in breast cancer, including the HER2-low cutoff
by: Agata Wróbel, et al.
Published: (2025-04-01)

Exploring the heterogeneity of HER2 gene status and expression in non-positive breast cancer patients: insights from immunohistochemistry and fluorescence in situ hybridization
by: Jingmin Zhong, et al.
Published: (2025-01-01)

Clinicopathological characteristics of placental chorioangioma: A clinicopathological study of 30 cases
by: Yuanyin Zheng, et al.
Published: (2024-12-01)

Clinical significance of HER2 overexpression in biliary tract carcinoma ——a meta analysis
by: Haonan Xu, et al.
Published: (2025-05-01)

Molecular Subtypes of Breast Carcinoma and Their Association with Clinicopathological Features
by: Ambreen Bari, et al.
Published: (2025-01-01)

Survival outcomes for HER2-low breast cancer: Danish national data
by: Michael Sode, et al.
Published: (2024-11-01)

BRCA1 expression in ovarian cancer and its relationship with clinicopathological characteristics and prognosis
by: Chenxiang Pan, et al.
Published: (2025-06-01)

Expression of FOXM1 and PLK1 in Colorectal Cancer and Their Relationship with Clinicopathological Features and Prognosis
by: Xue HAN, et al.
Published: (2025-07-01)

Immunohistochemical Breast Cancer Profiling Among Iraqi Women: Molecular Subtype Classification, Clinicopathology Associations, and Treatment‐Decision Making Tools: A Cross‐Sectional Study
by: Alaa Salah Jumaah, et al.
Published: (2025-05-01)

Analysis of factors influencing the efficacy of NAC and prognosis between HER2-zero and HER2-low HR negative breast cancer
by: Jing-Jing Liu, et al.
Published: (2024-11-01)

Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy
by: Yingbo Shao, et al.
Published: (2025-03-01)

Clinicopathological Characteristics of HER2-Positive Breast Cancer Patients with BRCA1/2 Pathogenic Variants and Their Response to Neoadjuvant Targeted Therapy
by: Xingyu LIAO, et al.
Published: (2025-06-01)

Clinicopathological feature and patterns of care of breast cancer patients in a peripheral tertiary care teaching institute: A retrospective analysis
by: Chayan Paul, et al.
Published: (2025-01-01)

The Clinicopathological and Prognostic Value of CCR7 Expression in Breast Cancer Throughout the Literature: A Systematic Review and Meta-Analysis
by: Mohamed Elhadary, et al.
Published: (2025-04-01)

Advances in research and current challenges in the treatment of advanced HER2-low breast cancer
by: Qiang Qin
Published: (2025-03-01)

HER2-low Breast Cancer: Salivary Metabolic Features and Therapeutic Perspectives
by: Lyudmila V. Bel’skaya
Published: (2025-06-01)

Conformal Prediction for Uncertainty Quantification and Reliable HER2 Status Classification in Breast Cancer IHC Images
by: Surayuth Pintawong, et al.
Published: (2025-01-01)

Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status
by: Yongtao Li, et al.
Published: (2025-06-01)

Clinicopathological, Histopathological, and Immunohistochemical Analysis of Mandibular Fibrosarcoma in a DSH Cat: A Case Report
by: Mahmood Ahmadi‐hamedani, et al.
Published: (2024-11-01)

Clinicopathological features and differential diagnosis of AIDS with CMV infection
by: ZENG Dong, SONG Shu, YANG Yuexiang, XU Jingjing, GUO Wenjuan, ZHENG Ye, SHI Yuhan, FENG Yanling
Published: (2025-06-01)

Clinicopathological features of hepatoid adenocarcinoma and non‐hepatoid adenocarcinoma of the stomach: A systematic review and meta‐analysis
by: Qi Ling, et al.
Published: (2024-08-01)

Relationship between expression of CEP55 in colorectal cancer tissues and clinicopathological characteristics and prognosis
by: Chen Weili, et al.
Published: (2024-04-01)

Trastuzumab deruxtecan for the late lines of treatment for HER2-low metastatic breast cancer: a clinical case
by: R. A. Murashko, et al.
Published: (2025-03-01)

Clinicopathological features and prognostic significance of TAF1L in gastric cancer
by: Han Chen, et al.
Published: (2024-12-01)

Clinicopathological features and prognosis analysis of postoperative bone metastasis of rectal cancer: a series of 42 cases
by: Li Guiting, et al.
Published: (2024-04-01)

Clinicopathologic characteristics and predictive nomogram of skip lymph node metastasis in gastric cancer
by: Xinwei Zhang, et al.
Published: (2025-08-01)

Potential prognostic value of HER2/CEP17 FISH ratio in HER2-positive non-metastatic breast cancer: a real-world study
by: Fangchao Zheng, et al.
Published: (2025-05-01)

Prevalence and concordance of HER2-low and HER2-ultralow status between historical and rescored results in a multicentre study of breast cancer patients in China
by: Hong Lv, et al.
Published: (2025-03-01)

Concordance of HER2-low scoring in breast carcinomas among pathologists
by: Snježana Tomić, et al.
Published: (2025-07-01)

Clinicopathological Study of Soft Tissue Tumors and Immunohistochemical Analysis
by: Arifa Sultana, et al.
Published: (2025-07-01)

Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization (FISH) scores from immunohistochemistry images via deep learning
by: Daniel O Macaulay, et al.
Published: (2025-03-01)

Excavating regulated cell death signatures to predict prognosis, tumor microenvironment and therapeutic response in HR+/HER2- breast cancer
by: Shuangshuang Mao, et al.
Published: (2024-12-01)

Expression Value of Rab10 in Breast Cancer
by: Jian Zhuo, et al.
Published: (2023-08-01)